Story · Medicine & Biotech
[Interview] Experts call for broader use of GLP-1 drugs in cardiovascular-kidney-metabolic care
1 outlet · first reported by Korea Biomedical Review on
For diabetes and obesity specialists, falling blood sugar levels and body weight have long been key measures of treatment success. But two experts say the focus needs to shift toward preventing cardiovascular and kidney complications and helping patients live longer, healthier lives.Professor Kang Y (Korea Biomedical Review)
Coverage, in order
-
[Interview] Experts call for broader use of GLP-1 drugs in cardiovascular-kidney-metabolic care
For diabetes and obesity specialists, falling blood sugar levels and body weight have long been key measures of treatment success. But two experts say the focus needs to shift toward preventing cardiovascular and kidney complications and helping patients live longer, healthier lives.Professor Kang Y
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.